Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
31,348,530
-
Share change
-
+30,903,518
-
Total reported value
-
$928,520,047
-
Price per share
-
$29.87
-
Number of holders
-
69
-
Value change
-
+$915,228,048
-
Number of buys
-
67
Institutional Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q4 2020
As of 31 Dec 2020,
Kronos Bio, Inc. - Common Stock (KRON) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,348,530 shares.
The largest 10 holders included
Omega Fund Management, LLC, Capital Research Global Investors, PERCEPTIVE ADVISORS LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, BlackRock Inc., Wildcat Capital Management, LLC, Alphabet Inc., and VANGUARD GROUP INC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.